Search results

How NICE uses cookies and how you can manage them.

To contact us, NICE's website is usually the quickest way to find the answer to a query.

Our staff really enjoy working with us, thanks to our great package of rewards and benefits.

Jobs in digital at NICE. Come and join us!

Jobs at NICE. Includes current vacancies, roles, location and salary information.

How to register as a stakeholder with NICE.

Find out more about the types of organisations that can register to be a stakeholder at NICE.

Home Freedom of information...

Ask an expert from NICE International, part of the UK's National Institute for Health and Care Excellence, to speak at a healthcare event in your country

The Innovative Licensing and Access Pathway (ILAP) is a unique initiative which works with medicine developers early on to help get new medicines to patients faster.

Evidence-based recommendations on intraoperative electron beam radiotherapy for locally advanced and locally recurrent colorectal cancer. This involves delivering electron beam radiation directly to the tumour during surgery. The aim is to stop the cancer from coming back and spreading further.

Result type

HealthTech guidance

Published

6 June 2023

Evidence-based recommendations on aortic valve reconstruction with glutaraldehyde-treated autologous pericardium for aortic valve disease in adults. This involves replacing the diseased part of the valve with some of the person’s own pericardium.

Result type

HealthTech guidance

Published

9 August 2023

Evidence-based recommendations on maximal cytoreductive surgery for advanced ovarian cancer. This involves removing all or almost all visible cancerous tissue. More tissue is removed than with standard surgery. The aim is to improve outcomes for people with advanced ovarian cancer.

Result type

HealthTech guidance

Published

5 April 2023

Evidence-based recommendations on autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy. This involves removing parts of the pancreas (islet cells) after the pancreas has been removed and inserting them into the liver to restart insulin production.

Result type

HealthTech guidance

Published

24 September 2008

Evidence-based recommendations on allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus. This involves removing cells called islet cells, which are responsible for the production of insulin, from human donors.

Result type

HealthTech guidance

Published

23 April 2008